Melissa Frei-Jones, M.D., MSCI

Associate Professor of Pediatrics
Fellowship Program Director
Director South Texas Hemophilia Treatment Center
Director South Texas Sickle Cell Center
Division of Hematology-Oncology
210-567-7480

Education:
MSCI, K30 Scholar, Washington University, St. Louis, 2008
MD, Pediatrics, University of Texas Southwestern Medical School, Dallas, TX, (Summa Cum Laude), 2002
BS, Latin American Studies, Southern Methodist University, Dallas, TX, (Summa Cum Laude), 1998
BA, Biology, Southern Methodist University, Dallas, TX, 1998

Training:
Fellowship, Pediatric Hematology-Oncology, Washington University School of Medicine, St. Louis, MO, 2005-2008

Residency:
Pediatrics, University of Texas Southwestern Medical School, Dallas, TX, 2002-2005

Certification:
Pediatrics, 2005; Hematology-Oncology, 2009 American Board of Pediatrics

Publications:
Kane LC, Woodward CS, Husain SA, Frei-Jones MJ. Thromboelastography–does it impact blood component transfusion in pediatric heart surgery? J Surg Res. 2016 Jan;200(1):21-7.

Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, McCastlain K, Ding L, Lu C, Song G, Ma J, Becksfort J, Rusch M, Chen SC, Easton J, Cheng J, Boggs K, Santiago-Morales N, Iacobucci I, Fulton RS, Wen J, Valentine M, Cheng C, Paugh SW, Devidas M, Chen IM, Reshmi S, Smith A, Hedlund E, Gupta P, Nagahawatte P, Wu G, Chen X, Yergeau D, Vadodaria B, Mulder H, Winick NJ, Larsen EC, Carroll WL, Heerema NA, Carroll AJ, Grayson G, Tasian SK, Moore AS, Keller F, Frei-Jones M, Whitlock JA, Raetz EA, White DL, Hughes TP, Guidry Auvil JM, Smith MA, Marcucci G, Bloomfield CD, Mrózek K, Kohlschmidt J, Stock W, Kornblau SM, Konopleva M, Paietta E, Pui CH, Jeha S, Relling MV, Evans WE, Gerhard DS, Gastier-Foster JM, Mardis E, Wilson RK, Loh ML, Downing JR, Hunger SP, Willman CL, Zhang J, Mullighan CG. 2014. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014 Sep 11;371(11):1005-15.

Jessen B, Bode SF, Ammann S, Chakravorty S, Davies G, Diestelhorst J, Frei-Jones M, Gahl WA, Gochuico BR, Griese M, Griffiths G, Janka G, Klein C, Kögl T, Kurnik K, Lehmberg K, Maul-Pavicic A, Mumford AD, Pace D, Parvaneh N, Rezaei N, de Saint Basile G, Schmitt-Graeff A, Schwarz K, Karasu GT, Zieger B, Zur Stadt U, Aichele P, Ehl S. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2. Blood. 2013 Apr 11;121(15):2943-51.

Gochuico BR, Huizing M, Golas GA, Scher CD, Tsokos M, Denver SD, Frei-Jones MJ, Gahl WA. Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease. Mol Med. 2012 Feb 10;18:56-64.

Regan MM, Debaun MR, Frei-Jones MJ. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome. Pediatric Blood Cancer 2011 Feb; 56(2):262-6.

Chiang PW, Spector E, Thomas M, Frei-Jones M. Novel mutation causing Hemansky-Pudlak Syndrome, Type 2. Pediatric Blood Cancer 2010 Dec 15(55(7): 1438.

Frei-Jones MJ, Field JJ, DeBaun MR. Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. Pediatric Blood Cancer 2009 Sept; 53(3):401-5.

Frei-Jones MJ, Field JJ, DeBaun MR. Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease.   Pediatr. Blood Cancer 2009 Apr; 52(4):481-5.

Frei-Jones M, McKinstry R, Perry A, Leonard JR, Park TS, Rubin JB. Use of thalidomide to diminish growth velocity in a life-threatening congenital hemangoma. J. Neurosurg. Pediatr. 2008 Aug;2(2);125-9.

Frei-Jones MJ, Baxter AL, Rogers ZR, Buchanan GR. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment. J. Pediatr. 2008 Feb;152(2):281-5.

Interests:
Sickle cell disease, coagulation disorders, benign hematology, vascular tumors